47 results
8-K
EX-99.1
VINC
Vincerx Pharma Inc
10 Nov 22
Vincerx Pharma Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
4:27pm
of approximately $1.0 million, partially offset by a decline in stock-based compensation expense of approximately $4.5 million.
General and administrative
8-K
EX-10.9
VINC
Vincerx Pharma Inc
30 Dec 20
Report of Independent Registered Public Accounting Firm
4:03pm
is not sufficient to fully reimburse Lessee on an offset basis, Lessee shall have the right to terminate this Lease upon 30 days written notice to Lessor.
(c … offset or deduction (except as specifically permitted in this Lease), on or before the day on which it is due. All monetary amounts shall be rounded
8-K
EX-99.1
VINC
Vincerx Pharma Inc
11 May 23
Vincerx Pharma Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:02pm
, manufacturing services associated with our ADC program of approximately $1.2 million, and clinical services of approximately $0.6 million, partially offset
8-K
EX-99.1
VINC
Vincerx Pharma Inc
14 Nov 23
Vincerx Pharma Reports Third Quarter 2023 Financial Results
12:00am
and clinical services of approximately $0.9 million, partially offset by the $1.0 million development milestone in connection with Vincerx’s IND filing
10-Q
lqwmqvznlvh lawxfv
6 May 20
Quarterly report
3:19pm
424B3
jq5scycgdce2rbyf1cqc
11 Jan 22
Prospectus supplement
4:04pm
10-K
gk8uj1mmk74
23 Sep 20
Annual report
3:07pm
8-K
EX-10.7
fkmyt2ybk8p sq9sn
30 Dec 20
Report of Independent Registered Public Accounting Firm
4:03pm
POS AM
xj5g18q80 52gfcu9
7 Jan 22
Prospectus update (post-effective amendment)
12:00am
424B3
l4s4wp877d
11 Jan 22
Prospectus supplement
4:04pm
POS AM
gkwtmns
7 Jan 22
Prospectus update (post-effective amendment)
12:00am